Oncology Precision Medicine Market Size, Share & Trends

Research Methodology – Oncology Precision Medicine Market

At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Oncology Precision Medicine Market comprises the following key stages:

Market Indicator & Macro-Factor Analysis

Our baseline thesis for the Oncology Precision Medicine Market is developed by integrating key market indicators and macroeconomic variables. These include:

Factors considered while calculating market size and share

Number of current and potential patients requiring oncology precision medicine
Existing competition level in the field
Entry and exit barriers in the Oncology Precision Medicine market
Government regulations and policies
Advancements in technologies and R&D activities
Total healthcare spending on cancer treatments

Key Market Indicators

Growth rate of cancer incidences globally
Patient demographic patterns
Number of precision medicine therapeutics in the pipeline
The rate of adoption of precision medicine in comparison to traditional therapies
Investments in Research and Development
Changes in market and product trends

Growth Trends

Increase in personalized patient care
Shift towards genomics-based cancer diagnosis and treatment
Increasing collaborations between pharmaceutical companies and diagnostic laboratories
Growth in targeted therapies
Increased governmental funding in precision medicine research

Secondary Research

Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Oncology Precision Medicine Market. Key inputs include:

Company-Level Information

Annual reports, investor presentations, SEC filings
Company press releases and product launch announcements
Public executive interviews and earnings calls
Strategy briefings and M&A updates

Industry and Government Sources

Country-level industry associations and trade bodies
Government dossiers, policy frameworks, and official releases
Whitepapers, working papers, and public R&D initiatives
Relevant Associations for the Oncology Precision Medicine Market

Market Intelligence Sources

Broker reports and financial analyst coverage
Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
Import/export trade data and tariff databases
Sector-specific journals, magazines, and news portals

Macro & Consumer Insights

Global macroeconomic indicators and their cascading effect on the industry
Demand–supply outlook and value chain analysis
Consumer behaviour, adoption rates, and commercialization trends

Primary Research

To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:

Expert Insights & KOL Engagements

Key Opinion Leader (KOL) Engagements
Structured interviews with executives, product managers, and domain experts
Paid and barter-based interviews across manufacturers, distributors, and end-users

Focused Discussions & Panels

Discussions with stakeholders to validate demand-supply gaps
Group discussions on emerging technologies, regulatory shifts, and adoption barriers

Data Validation & Business POV

Cross-verification of market sizing and forecasts with industry insiders
Capturing business perspectives on growth opportunities and restraints

Data Triangulation & Forecasting

The final step of our research involves data triangulation ensuring accuracy through cross-verification of:

Demand-side analysis (consumption patterns, adoption trends, customer spending)
Supply-side analysis (production, capacity, distribution, and market availability)
Macroeconomic & microeconomic impact factors

Forecasting is carried out using proprietary models that combine: